NCT05873309View on ClinicalTrials.gov

The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study

CompletedOBSERVATIONAL

Enrollment

386

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

September 23, 2024

Study Completion Date

December 31, 2024

Conditions

Acute Ischemic Stroke

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors

collaborator

Swiss Academy of Medical Sciences (SAMS)

OTHER

lead

University Hospital, Basel, Switzerland

OTHER